ストックスクリーナーアプリを入手
7.11
3.27%
-0.24
前日終値:
$7.35
開ける：
$7.29
24時間の取引高:
438.01K
Relative Volume:
0.64
時価総額：
$352.58M
収益：
$121.14M
当期純損益:
$-32.33M
株価収益率:
-8.2674
EPS:
-0.86
ネットキャッシュフロー:
$-22.69M
1週間 パフォーマンス:
-5.07%
1か月 パフォーマンス:
-11.79%
6か月 パフォーマンス:
-44.54%
1年 パフォーマンス:
-72.98%
1日の値動き範囲:
$7.08
$7.385
1週間の範囲:
$7.08
$7.82
52週間の値動き範囲:
$7.08
$27.37
Quanterix Corp Stock (QTRX) Company Profile
QTRX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
QTRX
Quanterix Corp
|
7.11 | 352.58M | 121.14M | -32.33M | -22.69M | -0.86 |
|
ABT
Abbott Laboratories
|
129.89 | 225.27B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
95.37 | 140.74B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
363.66 | 138.77B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
92.33 | 118.39B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
67.95 | 39.95B | 5.72B | 4.17B | 259.90M | 6.97 |
Quanterix Corp Stock (QTRX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-02-01 | 開始されました | Scotiabank | Sector Outperform |
| 2023-09-25 | アップグレード | Canaccord Genuity | Hold → Buy |
| 2023-08-08 | アップグレード | SVB Securities | Market Perform → Outperform |
| 2023-05-23 | アップグレード | Goldman | Neutral → Buy |
| 2022-08-15 | ダウングレード | Canaccord Genuity | Buy → Hold |
| 2022-08-09 | ダウングレード | Cowen | Outperform → Market Perform |
| 2022-08-09 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2022-03-02 | アップグレード | Goldman | Sell → Neutral |
| 2021-10-15 | 再開されました | Cowen | Outperform |
| 2021-06-04 | 開始されました | Goldman | Sell |
すべてを表示
Quanterix Corp (QTRX) 最新ニュース
Quanterix Corp (NASDAQ: QTRX) Is Down -1.62% – Is It Capable Of A Rally? - Stocks Register
Rhumbline Advisers Lowers Position in Quanterix Co. (NASDAQ:QTRX) - Defense World
Quanterix Corp [NASDAQ: QTRX] Sees Decrease in Stock Value - Knox Daily
Quanterix stock plunges to 52-week low of $7.3 amid market challenges - Investing.com
Can Quanterix's Akoya Acquisition Transform Biomarker Detection and Deliver $1B Revenue? - StockTitan
Quanterix (QTRX) Projected to Post Quarterly Earnings on Thursday - Defense World
Quanterix advances towards Akoya Biosciences acquisition By Investing.com - Investing.com Australia
Akoya Biosciences’ Merger with Quanterix Moves Forward - Investing.com India
Akoya Biosciences' Merger with Quanterix Moves Forward - Investing.com
Quanterix advances towards Akoya Biosciences acquisition - Investing.com
Quanterix stock plunges to 52-week low at $7.47 amid market challenges - Investing.com
Akoya climbs after merger deal with Quanterix - MSN
Kent Lake opposes Quanterix-Akoya merger, citing undervaluation - Investing.com
Quanterix Corporation Announcement: If You Have Suffered Losses in Quanterix Corporation (NASDAQ: QTRX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - GlobeNewswire Inc.
$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The MergerEVGR, QTRX, RKDA, EBTC - Marketscreener.com
Bullish Quanterix Insiders Loaded Up On US$831.7k Of Stock - Yahoo Finance
Understanding the Risks of Investing in Quanterix Corp (QTRX) - Knox Daily
Daily Progress: Quanterix Corp (QTRX) Drop -3.57, Closing at 7.83 - The Dwinnex
Quanterix Co. (NASDAQ:QTRX) Shares Purchased by abrdn plc - MarketBeat
Should You Expect Quanterix Corp (NASDAQ:QTRX) To Recover From Its -1.11% Drop From Highs? - Marketing Sentinel
The growth track for Quanterix Corp (QTRX) has changed recently - SETE News
AllianceBernstein L.P. Reduces Stake in Quanterix Corp - GuruFocus.com
Quanterix Corp Inc. (QTRX) Price Performance: A Comparative Analysis with Competitors - The InvestChronicle
Examining the Potential Price Growth of Quanterix Corp (QTRX) - Knox Daily
Trading Day Review: Quanterix Corp (QTRX) Loses Momentum, Closing at 8.83 - The Dwinnex
Quanterix sets 2025 executive incentive plan - MSN
Quanterix sets 2025 executive incentive plan By Investing.com - Investing.com Australia
2025-01-28 | QTRX Investor News: Rosen Law Firm Encourages Quanterix Corporation Investors to Inquire About Securities Class Action InvestigationQTRX | NDAQ:QTRX | Press Release - Stockhouse Publishing
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Quanterix CorporationQTRX - PR Newswire
Quanterix Nears All-Stock Deal for Akoya Biosciences - MSN
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Quanterix Corporation (QTRX) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Leerink Partnrs Lowers Earnings Estimates for Quanterix - Defense World
Leerink Partnrs Predicts Weaker Earnings for Quanterix - MarketBeat
JPMorgan Chase & Co. Acquires 47,873 Shares of Quanterix Co. (NASDAQ:QTRX) - Defense World
2025-01-18 | QTRX Investor News: Rosen Law Firm Encourages Quanterix Corporation Investors to Inquire About Securities Class Action InvestigationQTRX | NDAQ:QTRX | Press Release - Stockhouse Publishing
Quanterix stock reaffirms Buy rating, price target on mixed results By Investing.com - Investing.com South Africa
Quanterix stock reaffirms Buy rating, price target on mixed results - Investing.com
Quanterix reports steady growth amid challenging market By Investing.com - Investing.com Australia
Quanterix reports steady growth amid challenging market - Investing.com
Quanterix Achieves 12% Revenue Growth in 2024, Marks Seventh Quarter of Double-Digit Growth - StockTitan
Rosen Law Firm Encourages Quanterix Corporation Investors to Inquire About Securities Class Action InvestigationQTRX - PR Newswire
Quanterix merging with Akoya to bolster biomarker portfolio - BioWorld Online
Quanterix announces acquisition of Akoya Biosciences - Investing.com
Quanterix Prepares to Accelerate Market Development with First Integrated Solution for Ultra-Sensitive Detection of Biomarkers - Defense World
Billerica diagnostics maker Quanterix to acquire Marlborough biotech - The Business Journals
Quanterix Corp (QTRX) 財務データ
収益
当期純利益
現金流量
EPS
3.40%
0.89%
大文字化:
|
ボリューム (24 時間):